Modulation of mitomycin C-induced sister chromatid exchanges and cell cycle delay by buthionine sulfoximine and reduced glutathione in mouse bone marrow cells in vivo

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 413, Issue 3, 1998, Pages 227-234

  Dev Giri, S ^a   Chatterjee, A ^a  

^a School of Life Sciences   (India)

Author keywords

Bone marrow cell; Buthionine sulfoximine; Cell cycle delay; Glutathione; Sister chromatid exchange

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTATHIONE; MITOMYCIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL CYCLE; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BONE MARROW CELLS; BUTHIONINE SULFOXIMINE; CELL CYCLE; ENZYME INHIBITORS; GLUTATHIONE; MALE; MICE; MITOMYCIN; MUTAGENICITY TESTS; NUCLEIC ACID SYNTHESIS INHIBITORS; SISTER CHROMATID EXCHANGE;

ANIMALIA;

EID: 0032579747     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00023-0     Document Type: Article

References (41)

1. Tomasz M., Mercado C.M., Olson J., Chatterjee N. The mode of interaction of mitomycin C with deoxyribonucleic acid and other polypeptides in vitro. Biochemistry. 13:1974;4878.
2. Barlogie B., Drewinko B. Lethal and cytokinetic effects of mitomycin C on cultured human colon cancer cells. Cancer Res. 40:1980;1973-1980.
3. Sognier M.A., Hittelman W.N. Mitomycin-induced chromatid breaks in HeLa cells: a consequence of incomplete DNA replication. Cancer Res. 46:1986;4032-4040.
4. S.T. Crooke, Mitomycin C - an overview, in: S.T. Crooke, A.W. Prestayko (Eds.), Cancer and Chemotherapy, Vol. 3, Academic Press, New York, 1980, pp. 49-60.
5. Latt S.A. Sister chromatid exchanges, indices of human chromosome damage and repair: detection by fluorescence and induction of mitomycin C. Proc. Natl. Acad. Sci. U.S.A. 258:1974;121-125.
6. Perry P., Evans H.J. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchanges. Nature. 258:1975;121-125.
7. Stetka D.G., Minkler J.L., Carrano A.V. Induction of long-lived chromosome damage as manifested by sister chromatid exchange in lymphocytes of animals exposed to mitomycin C. Mutat. Res. 51:1978;383-396.
8. Held K.D., Harrop H.A., Michael B.D. Reaction kinetics of sulphydril containing compounds and oxygen with irradiated transforming DNA. Radiat. Res. 91:1982;304. (Abstract).
9. Chatterjee A., Jacob-Raman M. Modifying effect of reduced glutathione on X-ray-induced chromosome aberrations and cell cycle delay in muntjac lymphocytes in vitro. Mutat. Res. 175:1986;73-82.
10. Kosower N.S., Kosower E.M. The glutathione status of cells. Int. Rev. Cytol. 54:1978;109.
11. Shaw J.P., Chou I.N. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts. J. Cell Physiol. 129:1986;193-198.
12. Chatterjee A., Jacob-Raman M., Mohapatra B. Potentiation of bleomycin-induced chromosome aberrations by the radioprotector reduced glutathione. Mutat. Res. 214:1989;207-213.
13. Chattopadhyay A., Choudhury S., Chatterjee A. Modulation of the clastogenic activity of bleomycin by reduced-glutathione, glutathione-ester and buthionine sulfoximine. Mutagenesis. 12:1997;221-225.
14. Biaglow J.E., Clark E.P., Epp E.R., Morse-Guardio M., Varnes M.E., Mitchell J.B. Non-protein tiols and the radiation response AS49 human lung carcinoma cells. Int. J. Radiat. Biol. 44:1983;489-498.
15. Mitchell J.B., Morstyn G., Russo A., Carney D.N. In vitro radiobiology of human lung cancer. Cancer Treat. Symp. 2:1985;3.
16. Green J.A., Vistica D.T., Young R.C., Hamilton T.C., Rogan A.M., Ozols R.F. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res. 44:1984;5427-5431.
17. Hamilton T.C., Winker M.A., Lowe K.G. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug resistance and sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem. Pharmacol. 34:1985;2583-2587.
18. Arrick B.A., Nathan C.F. Glutathione metabolism as a determinant of therapeutic efficacy. Cancer Res. 44:1984;4224-4232.
19. Griffith O.W., Meister A. Translocation of intracellular glutathione to membrane bound γ-glutamyl transpeptidase as a discrete step in the γ-glutamyl cycle: glutathionuria after inhibition of transpeptidase. Proc. Natl. Acad. Sci. U.S.A. 76:1979;268-272.
20. Ono K., Shrieve D.C. Enhancement of EMT6/SF tumour cell killing by mitomycin C and cyclophosphamide following in vivo administration of buthionine sulfoximine. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1175.
21. Tsutsui K., Komuro C., Ono K., Nishidai T., Shibamato Y., Takahashi M., Abe M. Chromosensitization by buthionine sulfoximine in vivo. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1183-1185.
22. Goto K., Akematsu T., Shimagu H., Suigiyama T. Simple differential Giemsa staining of sister chromatids after treatment with photosensitive dyes and exposure to light and the mechanism of staining. Chromosoma. 53:1975;223-230.
23. G.W. Snedecor, W.G. Cochran, Statistical Methods, 6th edn, Iowa State Press, Ames, 1967.
24. Margolin B.H., Resnick M.A., Rimpo J.Y., Archer P., Galloway S.M., Bloom A.D., Zeiger E. Statistical analysis for in vitro cytogenetic assays using Chinese hamster ovary cell. Environ. Mutagen. 8:1986;183-204.
25. Lee F.Y.F., Allunis-Turner M.J., Siemann D.W. Depletion of tumour vs. normal tissue glutathione by buthionine sulfoximine. Br. J. Cancer. 56:1987;33-38.
26. Tice R.R., Ormiston B.G., McFee A.F. The effect of agent dose and treatment time on the intercellular distribution of sister chromatid exchanges induced by genotoxic agents in mouse bone marrow cells in vivo. Mutat. Res. 215:1989;25-37.
27. Chatterjee A., Chattopadhyay A., Lawlor C.J.Z. Effect of glutathione on sister chromatid exchanges in normal and buthionine sulfoximine-treated mice. Mutat. Res. 327:1995;171-177.
28. Singh S.V., Xu B.H., Maurya A.K., Mian M. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid. Biochem. Biophys. Acta. 1137:1992;257-263.
29. Sharma M., Tomasz M. Conjugation of glutathione and other thiols with bioreductively activated mitomycin C: effect of thiols on the reductive activation rate. Chem. Res. Toxicol. 7:1994;390-400.
30. Rainaldi R., Mariani T. The distribution of induced sister chromatid exchanges: a tool for identifying agents directly interacting with DNA. Mutat. Res. 103:1982;333-337.
31. MacRae W.D., MacKinnon E.A., Stich H.F. The fate of UV-induced lesions affecting SCEs, chromosome aberrations and survival of CHO cells arrested by deprivation of arginine. Chromosoma. 72:1979;15-22.
32. Ishii Y., Bender M.A. Effects of inhibitors of DNA synthesis on spontaneous and ultra-violet light-induced sister chromatid exchanges in Chinese hamster cells. Mutat. Res. 79:1982;19-32.
33. D.A. Shafer, Alternative replication bypass mechanisms for sister chromatid exchange formation, in: A.A. Sandberg (Ed.), Sister Chromatid Exchange, Alan R. Liss, New York, 1982, pp. 67-98.
34. Crooke S.T., Bradner W.T. Mitomycin C: a review. Cancer Treat. Rev. 3:1976;121-139.
35. Kennedy K.A., Mimnaugh E.G., Trush M.A., Sinha B.K. Effect of glutathione and ethylxanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumour nuclei. Cancer Res. 45:1985;4071-4076.
36. Lee J.H., Naito M., Tsuruo T. Non-enzymatic reductive activation of 7-N{{2-{[2-(-L-glutamylamino)ethyl]dithio}ethyl}mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumour cells. Cancer Res. 54:1994;2398-2403.
37. Glover D., Fox K.R., Weiler C., Kligerman M.M., Turrisi A., Glick J.H. Clinical trials of WR 2721 prior to alkylating agent in chemotherapy and radiotherapy. Pharmacol. Ther. 39:1988;3-7.
38. C.R. Wolf, A.D. Lewis, J. Carmichael, D.J. Adam, S.G. Allan, D.J. Anjell, The role of glutathione in determining the response of normal and tumour cells to anticancer drugs, 620th Meeting, Biochem. Society Transaction, Dublin, 1987.
39. Hoffmann G.R., Colyer S.P., Littlefield L.G. Induction of micronuclei by bleomycin in Go human lymphocytes: II. Potentiation by radioprotectors. Environ. Mol. Mutagen. 21:1993;136-143.
40. Levine A.J. p53, The cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
41. Fernandes R.S., Cotter T.G. Apoptosis and necrosis: intracellular levels of glutathione influence mode of cell death. Biochem. Pharmacol. 48:1994;675.